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145 mg/L on postoperative day 4), which predict the likelihood of developing or not developing infective complications and anastomotic leak [11] [12] .
The magnitude of this postoperative systemic inflammatory response and its relationship with postoperative complications is of particular interest in the context of surgery for gastrointestinal cancers. Previous studies have demonstrated an association between postoperative complications, particularly infective complications, and poorer long-term and oncologic outcomes following surgery for gastrointestinal cancer [13] [14] . Indeed, it has been suggested that the magnitude of the postoperative systemic inflammatory response should prompt further investigation to exclude the development of a postoperative infective complication [15] . Furthermore, the upcoming PRECious trial (NCT02102217) aims to randomize patients to early CT imaging or standard postoperative care if CRP rises above 140mg/L on postoperative day 3 to 5 following abdominal surgery [16] .
Given the relationship between the magnitude of the postoperative systemic inflammatory response, the development of postoperative complications, and long-term outcomes, there is increasing interest in the attenuation of this postoperative stress response.
Preoperative corticosteroids are a logical choice of intervention given their potential potency and duration of effect [17] [18] . Indeed, preoperative corticosteroids have been used as they have been found to reduce postoperative nausea and vomiting and analgesic requirements following abdominal surgery [19] [20] . A recent meta-analysis reported that preoperative corticosteroids significantly reduced postoperative day one IL-6, postoperative complications, infective complications, and length of stay following abdominal surgery [21] . Preoperative corticosteroids have also been reported to reduce postoperative IL-6 and complication rates following liver resection and oesophagectomy in meta-analyses of small numbers of studies [22] [23] [24] . To our knowledge, no prior meta-analysis has investigated comprehensively the impact of preoperative corticosteroids on the postoperative surgical stress response following surgery for gastrointestinal cancer. The present meta-analysis is the first to examine their impact on CRP. Both IL-6 and CRP are objective measures of the magnitude of the systemic inflammatory response to surgery, however CRP is more readily available in the clinical setting [7] . Furthermore, no meta-analysis has attempted to assess the dose response between preoperative corticosteroids and the magnitude of the postoperative systemic inflammatory response and postoperative complication rate.
Therefore the objective of the present systematic review and meta-analysis was to examine the impact of preoperative corticosteroids compared to placebo in the context of randomized controlled trials, on the surgical stress response, in particular postoperative IL 6 and CRP, and their relationship with the development of infective complications, following surgery for gastrointestinal cancers.
Methods
The present systematic review and meta-analysis was performed and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement (Supplementary Digital Content 1 -PRISMA Checklist.docx) [25] .
Outcomes of interest:
The primary outcome of interest was the impact of single dose preoperative corticosteroids on markers of the postoperative stress response following surgery for gastrointestinal cancer, in particular IL-6 and CRP. Those studies reporting chronic preoperative corticosteroid use or dosing at other perioperative time points were excluded.
Secondary outcomes included the impact of preoperative corticosteroids on postoperative complications, infective complications, and anastomotic leak following surgery for gastrointestinal cancer, including pre-specified subgroup analysis based on surgical speciality/site. Postoperative complications were coded as categorised by the authors of the included studies where possible. Where there was doubt the authors of the present study categorised complications using a schemata described previously [26] . Post hoc metaregression of the impact of corticosteroid dose on postoperative day 1 IL-6 was performed following completion of the pre-specified analyses. Study selection and data extraction was performed by one author (SM) and any uncertainties resolved by consensus discussion with the senior authors (PH, DM).
Literature search and study selection:
A systematic literature review was performed of the US National Library of Medicine (MEDLINE), PubMed, and the Cochrane Database of Systematic Reviews (CDSR) from inception to March 2015 inclusive. Subsequent to several pilot search strategies the following search term was used, "(cancer OR malignan* OR tumour OR tumor OR neoplasm*) AND (steroid OR corticosteroid OR glucocorticoid OR methylpredniso* OR predniso* OR dexamethasone) AND (surgery OR operati* OR perioperati* OR preoperati*) along with the Cochrane Highly Sensitive Search Strategy for RCTs [26] . Abstracts were screened for relevance and those studies which were animal and pre-clinical, those studies not published in English, and review articles were excluded. Relevant full text articles were then appraised.
Randomized controlled trials of single dose preoperative corticosteroids in surgery for gastrointestinal cancer which reported on a marker of the postoperative systemic inflammatory response and postoperative complications were included in the review. Reference lists of included studies were hand searched for further relevant studies.
Data extraction and meta-analysis:
Data from included studies was extracted to tables and analysis was performed using Review Manager version 5.3 (RevMan 5.3, The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark). Meta-analysis of the impact of corticosteroids on postoperative IL 6 and CRP was performed by calculating the mean difference and 95% confidence intervals (CI) using the inverse variance method and combining study outcomes using a random effects model. Where data other than means and standard deviations were reported an attempt was made to calculate these values using published confidence intervals or p values as described by Hozo and colleagues or by the Cochrane Handbook for Systematic
Reviews of Interventions [27] [28] . Results of the meta-analysis of the impact of corticosteroids on infective complications was assessed by odds ratios and 95% CIs using the Mantel-Haenzsel method and combining study outcomes using a random effects model. Peto odds ratios and their 95% CIs were combined using a fixed effects model to determine the impact of preoperative corticosteroids on anastomotic leak as there were a small number of events. Metaregression, using a random effects model, was performed with respect to the impact of corticosteroid dose on postoperative day 1 IL-6, following conversion to hydrocortisone equivalents using a freely [27] . Assessment of potential publication bias was carried out by visual inspection of funnel plots. P values ≤0.05 were considered statistically significant.
Results

Study selection process:
The study selection process is summarised in Figure 1 . Using the search protocol described, 2,428 abstracts were identified. At screening, 2,354 abstracts were excluded, of which 16 were animal or pre-clinical studies, 227 were not in the English language, 328 were review articles, 3 were duplicate publications and 1,780 were not relevant to the review. Full text articles were reviewed of the remaining 74 studies.
After assessment of full text articles 63 studies were excluded, of which 36 were not in gastrointestinal surgery patients, 6 did not include patients with malginancy, 14 did not include the intervention of interest or included corticosteroids at timings other than preoperatively, 3 did not measure either postoperative IL-6 or CRP, 2 used historical controls, 1 was a duplicate study, and 1 a co-intervention of epidural analgesia alongside preoperative corticosteroids. The remaining 11 randomised controlled trials including 474 patients were included in the review (Table 1) [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] .
Of the included studies, 3 including 139 patients were in colorectal surgery [38] [39] [40] , 4 including 156 patients were in oesophageal surgery [30, 32, [34] [35] , and 4 including 179 patients were in hepatic surgery [31, 33, [36] [37] . Of the 474 included patients, 436 ( 92%) had surgery for gastrointestinal cancer while 38 (8%) from 6 studies had surgery for benign gastrointestinal disease but were included in the meta-analysis [31, [36] [37] [38] 40] . All included patients underwent open surgery, no studies of minimally invasive surgery suitable for inclusion were returned by the search strategy.
Validity assessment:
The risk of study bias is summarised using the RevMan 5. 3.5 Impact of preoperative corticosteroid dose on postoperative IL-6 and CRP Within the 10 studies reporting postoperative day 1 IL-6, there was a wide variation in preoperative corticosteroid dose in the intervention arm [30] [31] [32] [33] [34] [35] [36] [37] [38] 40] . Following dose conversion to hydrocortisone equivalents (HEs) of both dexamethasone (1mg = 30 HEs) and methylprednisolone (1mg = 5 HEs) [29] , it was found that 2 studies gave patients 240 HEs 
Discussion
The present systematic review and meta-analysis reports that preoperative corticosteroids reduce the magnitude of the systemic inflammatory response, in particular IL-6 and CRP, and are significantly associated with fewer postoperative infective complications following surgery for gastrointestinal cancer.
The results of the present study with regard to postoperative IL-6 are consistent with recent meta-analyses of randomized controlled trials of preoperative corticosteroids in colorectal surgery, liver surgery and esophagectomy [21] [22] [23] [24] 41] . In addition, the present metaanalysis reports a significant reduction in IL-6 on postoperative days 2, 3 and 5 in those patients given preoperative corticosteroids. The present study reports a significant reduction in CRP on postoperative days 3 and 7 in those given preoperative corticosteroids however found no significant impact of preoperative corticosteroids on postoperative day 1 or 2. As CRP is usually seen to reach its peak concentration around 48 hours after the initial surgical insult it may be that comparison on postoperative day 1 and 2 does not accurately reflect the influence of preoperative corticosteroids on the postoperative systemic inflammatory response [6] . It is of interest that even within the control groups of the studies included in the present metaanalysis, the mean data were below postoperative CRP thresholds associated with the development of postoperative complications. For example, it has recently been advocated that simple objective postoperative CRP thresholds >150mg/l on post-operative days 3-5 be used to alert clinicians to the risk of post-operative complications before clinical signs and symptoms [42] . Moreover, when examined in detail by operative site, the mean CRP concentrations reported by the studies included in the present meta-analysis were significantly lower than values reported in a comprehensive systematic review of the timing and peak magnitude of postoperative IL-6 and CRP following elective colorectal, oesophageal and liver surgery [7] .
Therefore, it may be that patients recruited to previous randomised controlled trials of preoperative corticosteroids had a lower systemic inflammatory response compared with unselected patients. If this were to be the case then this may have implications for the randomised trials that reported efficacy of pre-operative corticosteroids on complication rates.
In particular, it may be that the efficacy was underestimated.
As with previous meta-analyses there was a wide variation in corticosteroid dose equivalence and timing [43] . The degree of heterogeneity between studies within each speciality in the present meta-analysis suggests that this does have an impact on the degree of attenuation of the postoperative systemic inflammatory response. Within the present metaanalysis, no significant association was found between varying corticosteroid dose equivalencies and postoperative day 1 IL-6 effect size between studies. However, this analysis was performed on a post hoc basis in response to data heterogeneity. In addition, dose timing and the differing half-life of dexamethasone and methylprednisolone were not considered and may be implicated [43] . The results of the present study do not define the ideal dose of preoperative corticosteroid to moderate the systemic inflammatory response or postoperative nausea and vomiting. For example, a recent meta-analysis of preoperative corticosteroids in the prevention of postoperative nausea and vomiting reported similar efficacy with lower doses of IV dexamethasone (4-5mg), when compared to higher doses (8-10mg) [44] . However, the efficacy of preoperative corticosteroids will depend on a number of factors including the magnitude of the systemic inflammatory response (eg. preventing patients breaching Postoperative IL-6 and CRP concentrations have been reported to be markers of the magnitude of the postoperative stress response [7] . In relation to short term postoperative morbidity, several recent meta-analyses have demonstrated the utility of elevated postoperative serum CRP in the early diagnosis of infective complications and anastomotic leak in gastrointestinal surgery [10, 12, 15] . In addition, the magnitude of the postoperative CRP has been reported to be associated with complication severity following colorectal surgery [45] [46] . Although this inflammatory response may represent an epiphenomenon rather than a cause of infective complications, given that the presence of a systemic inflammatory response (as evidenced by IL-6 or CRP) [7] is primarily an upregulated innate immune response (with consequent suppression of adaptive immunity), it is plausible that the magnitude of the postoperative systemic inflammatory response plays a role in the development of postoperative infective complications [47] . Indeed, the results of the present review are consistent with such a causal relationship. However, further interventional studies of preoperative corticosteroids would be required to prove such a relationship.
It is known that corticosteroids alter gene transcription and thus protein synthesis following intracellular receptor binding, however the exact mechanism by which they act to reduce inflammation is poorly understood [48] . Glucocorticoids act on the innate immune system including myeloid tissue, inhibiting the activity of neutrophils and macrophages via reduced transcription of several proinflammatory cytokines, and by increasing the transcription of lipocortins which themselves inhibit cyclo-oxygenase dependent inflammation pathways [49] . They are also recognised to have a down regulatory effect on adaptive immunity and lymphoid tissue, probably via inhibition of nuclear factor κB (NF-κB) [50] . The results of the present review taken with that of previous meta-analyses suggest that, in the postoperative period, the action of corticosteroid may at least be partly due to reduced transcription and production of IL-6 by innate immune cells, consequently reduced synthesis of CRP by hepatocytes [21, [23] [24] . Although both IL-6 and CRP are objective markers of the postoperative stress response and have both been associated with the development of complications following gastrointestinal surgery, CRP is routinely available in clinical practice [7] . Indeed, in a recent review of risk factors associated with anastomotic leak following colorectal surgery the authors advocate routine measurement of CRP on postoperative days 3 to 5, with a concentration greater than 150mg/L prompting the investigation of potentially developing complications [42] . In addition, other studies have investigated the use of other markers associated with the development of postoperative complications, for example procalcitonin, however the IMACORS study reported that CRP was more accurate in the detection of postoperative infective complications following colorectal surgery [51].
Furthermore, it has long been recognised that albumin is also a marker of the postoperative stress response [6] , and is associated with postoperative complications and mortality [52] . It remains to be determined whether albumin, in terms of predicting post-operative complication, offers prognostic value in addition to that of CRP and whether albumin may be a useful therapeutic target for pre-operative corticosteroids.
There has long been a concern regarding the inhibitory effect of corticosteroids on collagen formation leading to postoperative wound dehiscence and potentially anastomotic leak. However, the present meta-analysis along with prior randomised trials and meta-analyses have failed to demonstrate a significant increase in either complication in patients given corticosteroids [21, 24, [53] [54] . Much of the prior evidence regarding wound healing and infection has arisen from literature surrounding surgery for inflammatory bowel disease, in those undergoing transplant surgery, or in those with diseases of the hypothalamo-pituitaryadrenal axis [55] . Indeed, recent meta-analysis of both experimental and clinical trials suggests that receiving corticosteroids at standard therapeutic doses for 10 days or less is unlikely to impair wound healing [56] . Lastly, as recent preliminary reports suggest that preoperative corticosteroids may have a detrimental impact on oncologic outcome, some consideration should be given to their impact on longer term outcomes, especially in surgery for gastrointestinal cancer [57] [58] .
The main limitation of the present systematic review and meta-analysis is the relatively small number of patients included. To maximise the number of patients within the analysis several gastrointestinal surgical specialities were considered together using a random effects model. In addition there were a small number of patients included within the present metaanalysis who had undergone surgery for benign gastrointestinal disease. Indeed these factors, to an extent, limit the generalisability of the results of the present study. However, the exclusion of the 6 studies which included a small proportion of patients without malignant disease would have significantly reduced the power of the present meta-analysis [30, [35] [36] [37] 39] . A significant degree of heterogeneity was reported in the analysis of postoperative IL-6 and CRP. This may reflect the pooling of the various surgical specialities. However, no study individually reported a statistically significant increase in either postoperative IL-6 or CRP in the corticosteroid treatment group. Thus, although there are likely to be differences in the studied patient groups or methodology, the direction of the treatment effect at least, is very likely to be similar across the included studies. There was a wide variability in concentrations of IL 6 and CRP amongst studies within the same postoperative day. Both the biological variability of IL 6 and CRP, alongside the variety of surgical specialties included in the present study may account for this [59] . Other potential confounders include the use of a variety of preoperative corticosteroids, their dose and timing, although a random effects model was used as an attempt to minimise this, alongside meta-regression techniques. In addition, there may be a degree of publication bias toward positive results amongst the smaller studies included in the meta-analysis. In the present study, despite a broad and inclusive search strategy, there were no trials conducted in the USA included in the analysis. Therefore, it would appear that although preoperative corticosteroids are used in routine clinical practice in the USA, no formal Total events Heterogeneity: Chi² = 2.14, df = 2 (P = 0.34); I² = 6% Test for overall effect: Z = 0.37 (P = 0.71) 
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